Home / Daptomycin / United States
US ATC J01XX09 · updated 2 Nov 2026
Daptomycin shortage in United States
Is there a Daptomycin shortage in United States?
Yes. As of 2 Nov 2026, 2 Daptomycin products are reported short in United States, the first since 30 Jun 2026. No return date has been given. Main reason: not stated.
Also short in Canada, Italy, Spain, Australia. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Daptomycin, Injection, 500 mg/10 mL (NDC 0143-9378-01) discontinuation | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | 30 Jun 2026 | not given | Not stated |
| US | Daptomycin, Injection, 500 mg/10 mL (NDC 57884-3151-1) discontinuation | Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) | 30 Jun 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).